The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: A systematic review

Asian Journal of Andrology

Volumn 12, Issue 4, 2010, Pages 500-508

  Frieben, Ryan W ^a   Lin, Hao Cheng ^a,b   Hinh, Peter P ^a   Berardinelli, Francesco ^a,c   Canfield, Steven E ^a,d   Wang, Run ^a,d  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

benign prostatic hyperplasia; ejaculatory dysfunction; erectile dysfunction; minimally invasive surgery; sexual function; transurethral resection of the prostate

Indexed keywords

HOLMIUM; NEODYMIUM; THULIUM;

CLINICAL TRIAL; EJACULATION DISORDER; ERBIUM YAG LASER; HIGH INTENSITY FOCUSED ULTRASOUND; HOLMIUM LASER; HUMAN; INTERMETHOD COMPARISON; LASER COAGULATION; LASER SURGERY; PROSTATE HYPERTROPHY; REVIEW; SEXUAL FUNCTION; SHAM PROCEDURE; SYSTEMATIC REVIEW; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TRANSURETHRAL NEEDLE ABLATION; TRANSURETHRAL RESECTION; EJACULATION; ERECTILE DYSFUNCTION; LOW LEVEL LASER THERAPY; MALE; MICROWAVE RADIATION; MINIMALLY INVASIVE SURGERY; PENIS ERECTION; PHYSIOLOGY; PROCEDURES; PROSTATECTOMY; PROSTATIC HYPERPLASIA; RANDOMIZED CONTROLLED TRIAL (TOPIC);

EJACULATION; ERECTILE DYSFUNCTION; HUMANS; LASER THERAPY; MALE; MICROWAVES; MINIMALLY INVASIVE SURGICAL PROCEDURES; PENILE ERECTION; PROSTATECTOMY; PROSTATIC HYPERPLASIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 77954394365     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2010.33     Document Type: Review

References (34)

1. Taylor JM, DeSouza R, Wang R. Common approach to managing lower urinary tract symptoms and erectile dysfunction. Asian J Androl 2008; 10: 45-53.
2. Martin DJ, Mulhall JP. Enlarging the scope of managing benign prostatic hyperplasia: addressing sexual function and quality of life. Int J Clin Pract 2005; 59: 579-590
3. Berardinelli F, Hinh P, Wang R. Minimally invasive surgery in the management of benign prostatic hyperplasia. Minerva Urol Nefrol 2009; 61: 269-289
4. Basson R, Rees R, Wang R, Montejo AL, Incrocci L. Sexual function in chronic illness. J Sex Med 2010; 7: 374-388
5. Mottet N, Anidjar M, Bourdon O, Francois JF, Teillac P, et al. Randomized comparison of transurethral electrorection and holmium: YAG laser vaporization for symptomatic benign prostatic hyperplasia. J Endourol 1999; 13: 127-130 (Pubitemid 29176698)
6. Gillings PJ, Kennett KM, Fraundorfer MR. Holmium laser resection versus transurethral resection of the prostate: results of a randomized trial with 2 years of follow-up. J Endourol 2000; 14: 757-760
7. Tan AH, Gilling PJ, Kennett KM, Frampton C, Westenberg AM, et al. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol 2003; 170: 1270-1274 (Pubitemid 37108129)
8. Kuntz RM, Ahyai S, Lehrich K, Fayad A. Transurethral holmium laser enucleation of the prostate versus transure-thral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 2004; 172: 1012-1016 (Pubitemid 39096451)
9. Westenberg A, Gilling P, Kennett K, Frampton C, Fraundorfer M. Holmium laser resection of the prostate versus transurethral resection of the prostate: results of a randomized trial with 4-year minimum long-term follow-up. J Urol 2004; 172: 616-619 (Pubitemid 38900219)
10. Montorse F, Naspro R, Salonia A, Suardi N, Briganti A, et al. Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol 2004; 172: 1926-1929 (Pubitemid 39363092)
11. Briganti A, Naspro R, GallinaA, Salonia A, Vavassori I, et al. Impact of sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-center, randomized trial. J Urol 2006; 175: 1817-1821
12. Wilson LC, Gilling PJ, Williams A, Kennett KM, Frampton CM, et al. A randomized trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. Eur Urol 2006; 50: 569-573 (Pubitemid 44189064)
13. Meng F, Gao B, Fu Q, Liu Y, Shi B, et al. Change of sexual function in patients before and after Ho:YAG laser enucleation of the prostate. J Androl 2007; 28: 259-261 (Pubitemid 46423908)
14. Shingleton WB, Farabaugh P, May W. Three-year follow-up of laser prostatectomy versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology 2002; 60: 305-308 (Pubitemid 34831777)
15. Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello AJ. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol 2006; 20: 580-585 (Pubitemid 44689646)
16. Horasanli K, Silay MS, Altay B, Tanriverdi O, Sarica K, et al. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective rando miz ed trial. Urology 2008; 71: 247-251 (Pubitemid 351282348)
17. Malek RS, Kuntzman RS, Barrett DM. High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol 2000; 163: 1730-1733 (Pubitemid 30366723)
18. Hamann MF, Naumann CM, Seif C, van der Horst C, Junemann KP, et al. Functional outcome following photoselective vapori-za tion of the prostate (PVP): urodynamic findings within 12 months follow-up. Eur Urol 2008; 54: 902-910
19. Xia SJ, Zhuo J, Sun XW, Han BM, Shao Y, et al. Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 2008; 53: 382-390 (Pubitemid 350296567)
20. Fu WJ, Hong BF, Yang Y, Zhang X, Gao JP, et al. Vapo-resec tion for managing benign prostatic hyperplasia using a 2-μ m continuous-wave laser: a prospective trial with 1-year follow-up. BJU Int 2009; 103: 352-356
21. Cowles RS, Kabalin JN, Childs S, Lepor H, Dixon C, et al. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Urology 1995; 46: 155-160
22. Sengor F, Kose O, Yucebas E, Beysel M, Erdogan K, et al. A comparative study of laser ablation and transurethral electroresection for benign prostatic hyperplasia: results of a 6-month follow-up. Br J Urol 1996; 78: 398-400. (Pubitemid 27407863)
23. Norby B, Nielsen HV, Frimodt-Moller PC. Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs. transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyper-plasia. BJU Int 2002; 90: 853-862 (Pubitemid 36693618)
24. Arai Y, Aoki Y, Okubo K, Maeda H, Terada N, et al. Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study. J Urol 2000; 164: 1206-1211
25. Kabalin JN, Bite G, Doll S. Neodymium: YAG laser coagulation prostatectomy: 3 years of experience with 227 patients. J Urol 1996; 155: 181-185 (Pubitemid 126426461)
26. Ahmed M, Bell T, Lawrence WT, Ward JP, Watson GM. Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomized, controlled, parallel study. Br J Urol 1997; 79: 181-185 (Pubitemid 127798044)
27. Mattiasson A, Wagrell L, Schelin S, Nordling J, Richthoff J, et al. Five-year follow-up of feedback microwave thermo-therapy versus TRUP for clinical BPH: a prospective randomized multicenter study. Urology 2007; 69: 91-96 (Pubitemid 46161719)
28. Roehrborn CG, Preminger G, Newhall P, Denstedt J, Razvi H, et al. Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: results of a randomized, double-blind, multicenter, sham-controlled trial. Urology 1998; 51: 19-28. (Pubitemid 28092501)
29. Netto NR, Claro J, Cortado PL. Ejaculatory dysfunction after transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia. J Endourol 1994; 8: 217-219 (Pubitemid 24304822)
30. Bruskewitz R, Issa MM, Roehrborn CG, Naslund MJ, Perez-Marrero R, et al. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol 1998; 159: 1588-1593, discussion 1594. (Pubitemid 29117347)
31. Cimentepe E, Unsal A, Saglam R. Randomized clinical trial comparing transurethral needle ablation with transurethral resection of the prostate for the treatment of benign hyper-plasia: results at 18 months. J Endourol 2003; 17: 103-107 (Pubitemid 36348886)
32. Hill B, Belville W, Bruskewitz R, Issa M, Perez-Marrero R, et al. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol 2004; 171: 2336-2340 (Pubitemid 38625465)
33. Goya N, Ishikawa N, Ito F, Ryoji O, Tokumoto T, et al. Ethanol injection therapy of the prostate for benign prostatic hyperplasia: preliminary report on application of a new technique. J Urol 1999; 162: 383-386 (Pubitemid 29434345)
34. Grise P, Plante M, Palmer J, Martinez-Sagarra J, Hernandez C, et al. Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation. Eur Urol 2004; 46: 496-501; discussion 501-502 (Pubitemid 39200859)